(Q42346456)

27 October 2017

Comparable rate of EGFR kinase domain mutation in lung adenocarcinomas from Chinese male and female never-smokers (English)

1 reference

27 October 2017

1 reference

6

William Pao

1 reference

27 October 2017

Yi-hua Sun

1

1 reference

27 October 2017

Rong Fang

2

1 reference

27 October 2017

Bin Gao

3

1 reference

27 October 2017

Xiang-kun Han

4

1 reference

27 October 2017

Jun-hua Zhang

5

1 reference

27 October 2017

Hai-quan Chen

7

1 reference

27 October 2017

Hong-bin Ji

8

1 reference

27 October 2017

26 April 2010

1 reference

Acta Pharmacologica Sinica

27 October 2017

1 reference

27 October 2017

31

1 reference

27 October 2017

5

1 reference

27 October 2017

647-648

1 reference

https://scigraph.springernature.com/pub.10.1038/aps.2010.43

27 October 2017

0 references

cites work

Frequency of and variables associated with the EGFR mutation and its subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Epidermal growth factor receptor mutations in lung cancers.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990499

[EGFR gene mutation status among lung cancer patients in China]

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20418893

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/APS.2010.43

1 reference

27 October 2017

1 reference

27 October 2017

PubMed publication ID

20418893

1 reference